Plenderleith IH - Search Results

1

Adjuvant systemic therapy and survival after breast cancer.

Olivotto IA, Bajdik CD, Plenderleith IH, Coppin CM, Gelmon KA, Jackson SM, Ragaz J, Wilson KS, Worth A. Olivotto IA, et al. Among authors: plenderleith ih. N Engl J Med. 1994 Mar 24;330(12):805-10. doi: 10.1056/NEJM199403243301201. N Engl J Med. 1994. PMID: 8114832 Free article.

2

Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer.

Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE, Wilson KS, Knowling MA, Coppin CM, Paradis M, Coldman AJ, Olivotto IA. Ragaz J, et al. Among authors: plenderleith ih. N Engl J Med. 1997 Oct 2;337(14):956-62. doi: 10.1056/NEJM199710023371402. N Engl J Med. 1997. PMID: 9309100 Free article. Clinical Trial.

3

Phase I/II trial of biweekly paclitaxel and cisplatin in the treatment of metastatic breast cancer.

Gelmon KA, O'Reilly SE, Tolcher AW, Campbell C, Bryce C, Ragaz J, Coppin C, Plenderleith IH, Ayers D, McDermott B, Nakashima L, Healey D, Onetto N. Gelmon KA, et al. Among authors: plenderleith ih. J Clin Oncol. 1996 Apr;14(4):1185-91. doi: 10.1200/JCO.1996.14.4.1185. J Clin Oncol. 1996. PMID: 8648373 Clinical Trial.

4

Phase I trial of recombinant human granulocyte-macrophage colony-stimulating factor derived from yeast in patients with breast cancer receiving cyclophosphamide, doxorubicin, and fluorouracil.

O'Reilly SE, Gelmon KA, Onetto N, Parente J, Rubinger M, Page RA, Plenderleith IH. O'Reilly SE, et al. Among authors: plenderleith ih. J Clin Oncol. 1993 Dec;11(12):2411-6. doi: 10.1200/JCO.1993.11.12.2411. J Clin Oncol. 1993. PMID: 8246030 Clinical Trial.

5

Metastatic extraskeletal myxoid chondrosarcoma. Successful therapy with interferon alfa-2b.

Rubinger M, Plenderleith IH, Lertzman M, Worth AJ. Rubinger M, et al. Among authors: plenderleith ih. Chest. 1995 Jul;108(1):281-2. doi: 10.1378/chest.108.1.281. Chest. 1995. PMID: 7606973

6

Tamoxifen and conjugated estrogens (Premarin) followed by sequenced methotrexate and 5-FU in refractory advanced breast cancer.

Eisenhauer EA, Bowman DM, Pritchard KI, Paterson AH, Ragaz J, Plenderleith I, Geggie PH, Maxwell I. Eisenhauer EA, et al. Cancer Treat Rep. 1984 Nov;68(11):1421-2. Cancer Treat Rep. 1984. PMID: 6094005 No abstract available.

7

Bacille Calmette-Guérin as maintenance therapy for non-Hodgkin's lymphoma.

Thomas JW, Plenderleith IH, Landi S, Basco VE, Clements DV. Thomas JW, et al. Among authors: plenderleith ih. Can Med Assoc J. 1983 Sep 1;129(5):439-42. Can Med Assoc J. 1983. PMID: 6349765 Free PMC article. Clinical Trial.

8

Observations in immunotherapy of lymphoma and melanoma patients.

Thomas JW, Plenderleith IH, Clements DV, Landi S. Thomas JW, et al. Among authors: plenderleith ih. Clin Exp Immunol. 1975 Jul;21(1):82-96. Clin Exp Immunol. 1975. PMID: 1102163 Free PMC article.

9

Treating the treatment: toxicity of cancer chemotherapy.

Plenderleith IH. Plenderleith IH. Can Fam Physician. 1990 Oct;36:1827-30. Can Fam Physician. 1990. PMID: 21234006 Free PMC article.

10

Resuscitation of the terminally ill.

Plenderleith IH. Plenderleith IH. CMAJ. 1987 Apr 15;136(8):797. CMAJ. 1987. PMID: 3567783 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters